Ainos, Inc. (NASDAQ:AIMDW) Sees Significant Decrease in Short Interest

Ainos, Inc. (NASDAQ:AIMDW) was the recipient of a significant decline in short interest in February. As of February 27th, there was short interest totaling 3,421 shares, a decline of 23.0% from the February 12th total of 4,440 shares. Based on an average trading volume of 2,624 shares, the days-to-cover ratio is presently 1.3 days. Based on an average trading volume of 2,624 shares, the days-to-cover ratio is presently 1.3 days.

Ainos Price Performance

Shares of NASDAQ AIMDW opened at $0.09 on Friday. Ainos has a twelve month low of $0.06 and a twelve month high of $0.95. The firm has a 50-day moving average of $0.12 and a two-hundred day moving average of $0.14.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.